About: A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
Creator	Apolone, Giovanni Ciliberto, Gennaro Botti, Gerardo De Paoli, Paolo Paradiso, Angelo Silvestris, Nicola Costantini, Massimo Pronzato, Paolo De Maria, Ruggero Franceschi, Silvia Opocher, Giuseppe Sgambato, Alessandro
Source	Medline; PMC
abstract	If we focus our attention on seven main features of COVID-19 infection (heterogeneity, fragility, lack of effective treatments and vaccines, “miraculous cures”, psychological suffering, deprivation, and globalization), we may establish parallelism with the challenges faced in the steep road to the understanding and treatment of neoplastic diseases. How the similarities between these two conditions can help us cope with the emergency effort represented by the management of cancer patients in the COVID-19 era, today and in the future? In a manner similar to the Cancer Moonshot initiative in the United States, we can hypothesize a multinational moonshot project towards the management of cancer patients during COVID-19 pandemic. In particular, we believe that the main road to elaborate meaningful scientific evidence is represented by the collection of all the data on COVID-19 and cancer comorbidity that are and will become available in cancer centers, coupled with the design of large clinical studies. To address this goal, it is essential to identify the entity that can produce this scientific evidences and the potentially most successful research strategy to undertake. The largest Italian organization for cancer research, Alliance Against Cancer (Alleanza Contro il Cancro, ACC), is called to play a scientific leadership in addressing these challenges, which requires the coordination of oncology teams at regional, national, and international levels. To fulfill this commitment, ACC will create a liaison with health government agencies in order to develop “dynamic” indications able to fight such an unpredictable pandemic.
has issue date	2020-06-11(xsd:dateTime)
bibo:doi	10.1186/s13046-020-01614-x
bibo:pmid	32522223
has license	cc-by
sha1sum (hex)	6304155cbb32711c5679c740062f288db5bac7fa
schema:url	https://doi.org/10.1186/s13046-020-01614-x
resource representing a document's title	A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
has PubMed Central identifier	PMC7286743
has PubMed identifier	32522223
schema:publication	J Exp Clin Cancer Res
resource representing a document's body	covid:6304155cbb32711c5679c740062f288db5bac7fa#body_text
is schema:about of	named entity 'patients' named entity 'future' named entity 'infection' named entity 'represented' named entity 'national' named entity 'pandemic' named entity 'COORDINATION' named entity 'RESEARCH' named entity 'UNDERSTANDING' named entity 'PANDEMIC' named entity 'EMERGENCY' named entity 'patients' named entity 'evidences' named entity 'pandemic' named entity 'effective' named entity 'diseases' named entity 'cancer' named entity 'steep' named entity 'comorbidity' named entity 'Italian' named entity 'faced' named entity 'levels' named entity 'dynamic' named entity 'COVID-19' named entity 'management of cancer' named entity 'heterogeneity' named entity 'research strategy' named entity 'cancer research' named entity 'in-home' named entity 'Italy' named entity 'clinical practice' named entity 'Netherlands' named entity 'COVID' named entity 'PD-1' named entity 'tumors' named entity 'tumor' named entity 'malignancies' named entity 'infection' named entity 'SARS-CoV-2' named entity 'morbidity' named entity 'biobanks' named entity 'COVID' named entity 'informed consent' named entity 'respiratory symptoms' named entity 'globalization' named entity 'receptor' named entity 'adjuvant treatment' named entity 'ACC' named entity 'SARS-CoV-2' named entity 'virus' named entity 'long-term' named entity 'COVID' named entity 'COVID' named entity 'COVID' named entity 'infection' named entity 'COVID-19' named entity 'clinical trials' named entity 'anti-viral' named entity 'Italian Medicines Agency' named entity 'COVID-19' named entity 'patient care' named entity 'immunotherapy' named entity 'pandemics' named entity 'COVID' named entity 'United States' named entity 'oncology research' named entity 'tumor' named entity 'oncological' named entity 'virus' named entity 'Italian Ministry of Health'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software